Agenus CEO Garo Armen Receives 4,852-Share Award

What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), received 4,852 shares on July 10, 2026 as compensation (salary paid in stock). The shares were issued at $3.35 per share (closing price on July 10), for a notional value of $16,254. The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and were fully vested on the date of issuance.

Key Details

• Transaction date: July 10, 2026 (Form 4 filed July 14, 2026; within the two-business-day reporting window).
• Transaction type/code: Award/other acquisition (A) — salary converted to stock at $3.35/share.
• Shares acquired: 4,852; value ≈ $16,254 (using $3.35 closing price).
• Vesting: Shares were fully vested on issuance (per footnote).
• Holding: These shares are held in Dr. Armen’s IRA accounts.
• Other disclosed holdings: Dr. Armen is trustee/has investment authority for 23,950 shares held by the Garo Armen 2020 2 Year AG GRAT and has an affiliation with Pixie Partners, which holds 5,000 shares (he disclaims beneficial ownership to the extent of his pecuniary interest in Pixie).
• Filing timeliness: Reported timely (no late filing indicated).

Context
This was a compensation issuance (salary paid in stock), not an open-market buy or sale. Such stock-for-salary conversions are routine corporate compensation actions and do not, by themselves, indicate a buy or sell signal.